Plain-English translation of NCT07093138 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Researchers are testing Canvert-M, a roll-on medication containing cannabidiol (a compound from cannabis) blended with peppermint, lavender, and other soothing oils. The goal is to see whether applying this mixture to your forehead, temples, behind your ears, and neck during a migraine can safely reduce your pain. This is a Phase 4 trial, meaning the medication has been tested before—now researchers want to confirm it works well for migraine sufferers.
Many people with migraines need better treatment options that work quickly and have fewer side effects. Researchers want to know if this topical treatment can ease migraine pain without requiring pills or injections.
You likely qualify if…
You likely don't qualify if…
When you have a migraine attack, you will apply the roll-on medication to your forehead, temples, behind your ears, and the base of your neck. You'll then record your pain level at several time points: right before using it, and then at 30 minutes, 1 hour, 2 hours, 4 hours, and 24 hours afterward using a simple pain scale. If your headache hasn't improved after 30 minutes, you can apply a second dose. You'll avoid using other pain medications for at least two hours, and you'll keep a simple log of how well the treatment worked overall.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Iran